Lv43
636 积分 2024-06-20 加入
胶质瘤分子病理诊断中国专家共识（2025版）
5天前
已完结
[Clinical practice guideline for molecular pathology in colorectal cancer (2025 version)]
1个月前
已完结
Cytology‐histology correlation of myoepithelial tumors harboring EWSR1‐POU5F1 fusions: A report of two cases
2个月前
已完结
Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome
2个月前
已完结
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2
3个月前
已关闭
FURVENT: Phase 3 trial of firmonertinib vs chemotherapy as first-line treatment for advanced NSCLC with EGFR exon 20 insertion mutations (FURMO-004)
4个月前
已完结
Mutation detection rates associated with specific selection criteria for BRCA1/2 testing in 1854 high-risk families: A monocentric Italian study
4个月前
已完结
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)
4个月前
已完结
中国乳腺癌PIK3CA基因突变检测专家共识（2025版）
4个月前
已完结
皖公网安备34019202002308
